SOLANA BEACH, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling...
BELFAST, Northern Ireland, Sept. 10, 2025 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing...
SANTA CLARA, CA / ACCESS Newswire / September 9, 2025 / For many patients with life-threatening conditions, time is a...
Doceree launches its unique AI-powered solution at Fierce Pharma Week 2025, empowering pharma manufactures and marketers with the first-of-its-kind ad...
Doceree launches its unique AI-powered solution at Fierce Pharma Week 2025, empowering pharma manufactures and marketers with the first-of-its-kind ad...
Next-generation technology enhances precision, improves patient outcomes, and expands minimally invasive surgery across Long Beach, Fountain Valley and Laguna Hills....
Next-generation technology enhances precision, improves patient outcomes, and expands minimally invasive surgery across Long Beach, Fountain Valley and Laguna Hills....
Randomized trial demonstrates text messaging platform can increase walking by nearly 2 hours per week among participants SAN FRANCISCO, Sept....
Randomized trial demonstrates text messaging platform can increase walking by nearly 2 hours per week among participants SAN FRANCISCO, Sept....
Pilot program, with support from Sanofi, aims to accelerate identification of presymptomatic, early-stage T1D using cutting-edge AI and readily available...
Pilot program, with support from Sanofi, aims to accelerate identification of presymptomatic, early-stage T1D using cutting-edge AI and readily available...
The landmark multiomics study will examine how lifestyle, environmental, socioeconomic, and genetic factors play a significant role in shaping common...
The landmark multiomics study will examine how lifestyle, environmental, socioeconomic, and genetic factors play a significant role in shaping common...
Worldwide clinical PERIBLOOD™ trial by the Weizmann Institute to evaluate single cell RNA sequencing from blood as a Non-Invasive Path...
Worldwide clinical PERIBLOOD™ trial by the Weizmann Institute to evaluate single cell RNA sequencing from blood as a Non-Invasive Path...
In this free webinar, gain insight into the benefits and challenges of utilizing electronic health record (EHR) data as a...
In this free webinar, gain insight into the benefits and challenges of utilizing electronic health record (EHR) data as a...
Integration of PhaseV's Trial Optimizer with Bioforum's Biometric CRO Services Creates an End-to-End Solution for Smarter, Faster, and More Efficient...
Integration of PhaseV's Trial Optimizer with Bioforum's Biometric CRO Services Creates an End-to-End Solution for Smarter, Faster, and More Efficient...
In this free webinar, gain insight into strategies to improve data quality monitoring in rare disease clinical trials, including eCOA form optimization,...